ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
3 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
318
|
84K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
318
|
84K
|
2
|
|
ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
4 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
318
|
84K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
trcb
|
172 |
49K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
172
|
49K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
trcb
|
172 |
49K |
0 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
172
|
49K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
5 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
318
|
84K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
British journal of GPs ...pneumonia
|
|
trcb
|
28 |
10K |
0 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
28
|
10K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
trcb
|
172 |
49K |
0 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
172
|
49K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
4 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
318
|
84K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
3 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
318
|
84K
|
3
|
|
ASX - By Stock
|
LPE |
Re:
News: LPE AD1 Holdings Says Unit Signed 5-Yr Agreement With LPE
|
|
trcb
|
11 |
3.3K |
0 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
11
|
3.3K
|
0
|
|
ASX - By Stock
|
AD1 |
Re:
Ann: AD1 signs 5-year $10 million agreement
|
|
trcb
|
37 |
8.6K |
5 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
37
|
8.6K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Media Reports
|
|
trcb
|
318 |
84K |
3 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
318
|
84K
|
3
|
|
ASX - By Stock
|
AD1 |
Re:
Ann: AD1 signs 5-year $10 million agreement
|
|
trcb
|
37 |
8.6K |
1 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
37
|
8.6K
|
1
|
|
ASX - By Stock
|
AD1 |
Re:
Ann: AD1 signs 5-year $10 million agreement
|
|
trcb
|
37 |
8.6K |
3 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
37
|
8.6K
|
3
|
|
ASX - By Stock
|
AD1 |
Re:
Ann: AD1 signs 5-year $10 million agreement
|
|
trcb
|
37 |
8.6K |
2 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
37
|
8.6K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Final Director's Interest Notice
|
|
trcb
|
33 |
6.4K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
33
|
6.4K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
3 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
314
|
82K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
1 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
314
|
82K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
3 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
122
|
24K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
2 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
2
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
2 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
4 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
3 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
0 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
3 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Successful Completion of Infant Face-Only Clinical Study
|
|
trcb
|
93 |
27K |
0 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
93
|
27K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
1 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
3 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
2 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
3 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
2 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
3 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
2 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Appendix 4C - quarterly
|
|
trcb
|
15 |
3.1K |
2 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
15
|
3.1K
|
2
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Successful Completion of Infant Face-Only Clinical Study
|
|
trcb
|
93 |
27K |
15 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
93
|
27K
|
15
|
|
ASX - By Stock
|
RSH |
Re:
Ann: SuperChem to Commence Sales of wheezo
|
|
trcb
|
122 |
24K |
6 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
122
|
24K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
trcb
|
314 |
82K |
6 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
314
|
82K
|
6
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Appendix 4C - quarterly
|
|
trcb
|
15 |
3.1K |
2 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
15
|
3.1K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Final Director's Interest Notice
|
|
trcb
|
33 |
6.4K |
0 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
33
|
6.4K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Final Director's Interest Notice
|
|
trcb
|
33 |
6.4K |
0 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
33
|
6.4K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Final Director's Interest Notice
|
|
trcb
|
33 |
6.4K |
0 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
33
|
6.4K
|
0
|
|